Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$10.05 - $12.02 $72,741 - $87,000
-7,238 Reduced 27.3%
19,273 $204,000
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $18,843 - $22,622
-1,672 Reduced 5.93%
26,511 $316,000
Q4 2023

Jan 30, 2024

SELL
$8.77 - $10.85 $72,826 - $90,098
-8,304 Reduced 22.76%
28,183 $305,000
Q3 2023

Oct 23, 2023

BUY
$9.59 - $11.35 $41,467 - $49,077
4,324 Added 13.44%
36,487 $359,000
Q2 2023

Jul 24, 2023

BUY
$9.02 - $10.29 $16,930 - $19,314
1,877 Added 6.2%
32,163 $320,000
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $24,839 - $33,102
2,700 Added 9.79%
30,286 $291,000
Q4 2022

Feb 10, 2023

BUY
$8.72 - $11.56 $96,966 - $128,547
11,120 Added 67.53%
27,586 $307,000
Q3 2022

Nov 09, 2022

BUY
$8.48 - $11.13 $24,592 - $32,277
2,900 Added 21.38%
16,466 $140,000
Q2 2022

Aug 16, 2022

SELL
$9.95 - $12.27 $10,746 - $13,251
-1,080 Reduced 7.37%
13,566 $142,000
Q1 2022

May 13, 2022

SELL
$9.81 - $15.4 $31,764 - $49,865
-3,238 Reduced 18.11%
14,646 $159,000
Q4 2021

Feb 15, 2022

BUY
$12.09 - $14.68 $12,222 - $14,841
1,011 Added 5.99%
17,884 $242,000
Q3 2021

Nov 09, 2021

SELL
$13.25 - $15.13 $33,708 - $38,490
-2,544 Reduced 13.1%
16,873 $228,000
Q2 2021

Aug 13, 2021

SELL
$12.97 - $16.15 $62,320 - $77,600
-4,805 Reduced 19.84%
19,417 $277,000
Q1 2021

May 11, 2021

SELL
$13.59 - $18.54 $420,692 - $573,924
-30,956 Reduced 56.1%
24,222 $339,000
Q4 2020

Feb 10, 2021

BUY
$14.3 - $18.74 $789,045 - $1.03 Million
55,178 New
55,178 $1.03 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.